{
  "docId": "019dd923-622c-750b-8b9a-ad0811d3e80d",
  "docSlug": "dfcef8f28a20",
  "documentTitle": "Accelerate Diagnostics (AXDX)",
  "authorId": "61_White_Diamond_Research",
  "authorName": "White Diamond Research",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-09-16 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 2,
  "pageCount": 41,
  "prevPage": 1,
  "nextPage": 3,
  "slideType": "executive_summary",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 8,
  "notes": "This is a short-seller research note highlighting discrepancies between market valuation and actual commercial performance.",
  "elementsJson": [
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-ad0811d3e80d/2",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d#slide-2",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "In contrast to enthusiastic AXDX bulls, hospitals largely ignore the Pheno system.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-78b4-70ad-b39f-a0c5163e5e23",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.764,
        "x": 0.118,
        "y": 0.232
      },
      "kind": "paragraph",
      "text": "In contrast to enthusiastic AXDX bulls, hospitals largely ignore the Pheno system. AXDX's 2018 annual revenue was only $5.6M. Both Q1 and Q2 2019 revenues were a meager $1.8M.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d6f7807-2fbc-44ee-ab35-09166c60b9ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.764,
        "x": 0.118,
        "y": 0.446
      },
      "kind": "paragraph",
      "text": "AXDX was formerly known as Accelr8 Technology Corporation. Accelr8 was run by a team of software engineers with some shady histories. In January 2001, Accelr8 purchased the OpTest technology assets from DDx, Inc. for $0.5M in cash and $2.5M in stock.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d2927c8-1f84-4cb0-a60f-37e210e4d629",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.041,
        "w": 0.764,
        "x": 0.118,
        "y": 0.748
      },
      "kind": "paragraph",
      "text": "Today, AXDX shares are largely controlled by the Directors and largest shareholders, such as Jack Schuler, Larry Feinberg from Oracle investments, and Larry Mehren, AXDX's current CEO.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cf0c83f1-2a00-4377-bd0f-b6e52bcb0813",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.764,
        "x": 0.118,
        "y": 0.095
      },
      "kind": "paragraph",
      "text": "For a brief background, AXDX claims that it founded the Holy Grail of rapid sepsis diagnostics, because it delivers both bacteria type identification (ID) and anti-microbial susceptibility (AST) data faster than conventional cell culture testing.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d447004b-1dd0-4dd2-be92-d8d195473c80",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.022,
        "w": 0.465,
        "x": 0.118,
        "y": 0.403
      },
      "kind": "title",
      "text": "Accelerate's History And Tight Insider Control",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "73c2ffa3-8343-49c5-9678-030932ceb0be",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}